ARISOY, M. Et Al. 2022. A Study to Compare Bioequivalence Approach Between FDA and EMA in a Highly Variable Drug: Pinaverium Bromide Film Tablets. Journal of Pharmaceutical Sciences , vol.111, no.11 , 3149-3154.

ARISOY, M., Saydam, M., Ekin Dolaksız, Y., Talay, Ç., Sağlam, O., Demiray, G., ... Doğan Kurtoğlu, E.(2022). A Study to Compare Bioequivalence Approach Between FDA and EMA in a Highly Variable Drug: Pinaverium Bromide Film Tablets. Journal of Pharmaceutical Sciences , vol.111, no.11, 3149-3154.

ARISOY, MUSTAFA Et Al. "A Study to Compare Bioequivalence Approach Between FDA and EMA in a Highly Variable Drug: Pinaverium Bromide Film Tablets," Journal of Pharmaceutical Sciences , vol.111, no.11, 3149-3154, 2022

ARISOY, MUSTAFA Et Al. "A Study to Compare Bioequivalence Approach Between FDA and EMA in a Highly Variable Drug: Pinaverium Bromide Film Tablets." Journal of Pharmaceutical Sciences , vol.111, no.11, pp.3149-3154, 2022

ARISOY, M. Et Al. (2022) . "A Study to Compare Bioequivalence Approach Between FDA and EMA in a Highly Variable Drug: Pinaverium Bromide Film Tablets." Journal of Pharmaceutical Sciences , vol.111, no.11, pp.3149-3154.

@article{article, author={MUSTAFA ARISOY Et Al. }, title={A Study to Compare Bioequivalence Approach Between FDA and EMA in a Highly Variable Drug: Pinaverium Bromide Film Tablets}, journal={Journal of Pharmaceutical Sciences}, year=2022, pages={3149-3154} }